Aspreva, Roche Will Not Advance CellCept For Lupus Nephritis

 
• By Pamela Taulbee

Aspreva continues Phase III trial of CellCept to treat autoimmune disease pemphigus vulgaris.

More from Archive

More from Pink Sheet